| UniProt ID | TIGAR_HUMAN | |
|---|---|---|
| UniProt AC | Q9NQ88 | |
| Protein Name | Fructose-2,6-bisphosphatase TIGAR {ECO:0000305} | |
| Gene Name | TIGAR {ECO:0000303|PubMed:16839880} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 270 | |
| Subcellular Localization | Cytoplasm . Nucleus . Mitochondrion . Translocated to the mitochondria during hypoxia in a HIF1A-dependent manner (PubMed:23185017). Colocalizes with HK2 in the mitochondria during hypoxia (PubMed:23185017). Translocated to the nucleus during hypoxia | |
| Protein Description | Fructose-bisphosphatase hydrolyzing fructose-2,6-bisphosphate as well as fructose-1,6-bisphosphate. [PubMed: 19015259 Acts as a negative regulator of glycolysis by lowering intracellular levels of fructose-2,6-bisphosphate in a p53/TP53-dependent manner, resulting in the pentose phosphate pathway (PPP) activation and NADPH production] | |
| Protein Sequence | MARFALTVVRHGETRFNKEKIIQGQGVDEPLSETGFKQAAAAGIFLNNVKFTHAFSSDLMRTKQTMHGILERSKFCKDMTVKYDSRLRERKYGVVEGKALSELRAMAKAAREECPVFTPPGGETLDQVKMRGIDFFEFLCQLILKEADQKEQFSQGSPSNCLETSLAEIFPLGKNHSSKVNSDSGIPGLAASVLVVSHGAYMRSLFDYFLTDLKCSLPATLSRSELMSVTPNTGMSLFIINFEEGREVKPTVQCICMNLQDHLNGLTETR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 18 | Ubiquitination | HGETRFNKEKIIQGQ CCCCCCCHHHHHCCC | 58.64 | 22817900 | |
| 20 | Acetylation | ETRFNKEKIIQGQGV CCCCCHHHHHCCCCC | 46.87 | 23236377 | |
| 20 | Malonylation | ETRFNKEKIIQGQGV CCCCCHHHHHCCCCC | 46.87 | 26320211 | |
| 20 | Ubiquitination | ETRFNKEKIIQGQGV CCCCCHHHHHCCCCC | 46.87 | 21906983 | |
| 34 | Phosphorylation | VDEPLSETGFKQAAA CCCCCCHHCHHHHHH | 44.54 | 22817900 | |
| 37 | Ubiquitination | PLSETGFKQAAAAGI CCCHHCHHHHHHHCH | 40.13 | 21906983 | |
| 37 | Methylation | PLSETGFKQAAAAGI CCCHHCHHHHHHHCH | 40.13 | 42373057 | |
| 50 | Acetylation | GIFLNNVKFTHAFSS CHHHCCCCCCCCCCH | 46.82 | 19608861 | |
| 61 | Methylation | AFSSDLMRTKQTMHG CCCHHHHHCHHHHHH | 46.17 | 115918477 | |
| 63 | Ubiquitination | SSDLMRTKQTMHGIL CHHHHHCHHHHHHHH | 33.15 | 29967540 | |
| 80 | Phosphorylation | SKFCKDMTVKYDSRL HHHHCCCCCEECHHH | 24.79 | - | |
| 82 | Acetylation | FCKDMTVKYDSRLRE HHCCCCCEECHHHHH | 33.89 | 26051181 | |
| 83 | Phosphorylation | CKDMTVKYDSRLRER HCCCCCEECHHHHHH | 18.15 | - | |
| 85 | Phosphorylation | DMTVKYDSRLRERKY CCCCEECHHHHHHHC | 30.08 | - | |
| 91 | Ubiquitination | DSRLRERKYGVVEGK CHHHHHHHCCEECCH | 41.42 | 29967540 | |
| 92 | Phosphorylation | SRLRERKYGVVEGKA HHHHHHHCCEECCHH | 22.75 | 29496907 | |
| 98 | Ubiquitination | KYGVVEGKALSELRA HCCEECCHHHHHHHH | 32.42 | 24816145 | |
| 101 | Phosphorylation | VVEGKALSELRAMAK EECCHHHHHHHHHHH | 39.17 | - | |
| 129 | 2-Hydroxyisobutyrylation | GETLDQVKMRGIDFF CCCHHHHHHCCCCHH | 19.76 | - | |
| 129 | Ubiquitination | GETLDQVKMRGIDFF CCCHHHHHHCCCCHH | 19.76 | 24816145 | |
| 150 | Ubiquitination | ILKEADQKEQFSQGS HHHHHHHHHHHHCCC | 54.77 | 29967540 | |
| 154 | Phosphorylation | ADQKEQFSQGSPSNC HHHHHHHHCCCCCHH | 33.07 | 17525332 | |
| 157 | Phosphorylation | KEQFSQGSPSNCLET HHHHHCCCCCHHHHH | 19.95 | 21712546 | |
| 159 | Phosphorylation | QFSQGSPSNCLETSL HHHCCCCCHHHHHHH | 41.70 | 28464451 | |
| 164 | Phosphorylation | SPSNCLETSLAEIFP CCCHHHHHHHHHHCC | 18.98 | 22199227 | |
| 165 | Phosphorylation | PSNCLETSLAEIFPL CCHHHHHHHHHHCCC | 19.06 | 22199227 | |
| 174 | Ubiquitination | AEIFPLGKNHSSKVN HHHCCCCCCCCCCCC | 60.20 | 29967540 | |
| 182 | Phosphorylation | NHSSKVNSDSGIPGL CCCCCCCCCCCCCCH | 35.82 | 20068231 | |
| 184 | Phosphorylation | SSKVNSDSGIPGLAA CCCCCCCCCCCCHHH | 38.14 | 20068231 | |
| 192 | Phosphorylation | GIPGLAASVLVVSHG CCCCHHHHHEHHCCC | 15.46 | 20068231 | |
| 197 | Phosphorylation | AASVLVVSHGAYMRS HHHHEHHCCCHHHHH | 14.55 | 20068231 | |
| 201 | Phosphorylation | LVVSHGAYMRSLFDY EHHCCCHHHHHHHHH | 9.54 | 20068231 | |
| 204 | Phosphorylation | SHGAYMRSLFDYFLT CCCHHHHHHHHHHHH | 19.50 | 21712546 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TIGAR_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TIGAR_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TIGAR_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| UB2L3_HUMAN | UBE2L3 | physical | 22939629 | |
| TSC2_HUMAN | TSC2 | physical | 22939629 | |
| RL11_HUMAN | RPL11 | physical | 21988832 | |
| PCBP1_HUMAN | PCBP1 | physical | 26344197 | |
| TKT_HUMAN | TKT | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-50, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154, AND MASSSPECTROMETRY. | |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-34, AND MASSSPECTROMETRY. | |